Medically reviewed by Andrew Greenberg, MD Optometrists (healthcare providers who offer standard eye care) can diagnose wet ...

In celebration of Ophthalmology Times' 50th anniversary, we asked leading experts in the field what they see as the biggest ...

If approved, Eylea would be the first treatment for RVO with 8-week dosing. The FDA target action date is Aug. 19, 2025.

Medically reviewed by Christine L. Larsen, MD Myopic macular degeneration (MMD), or pathological myopia, occurs when high ...

your eye care specialist may use the following diagnostic tests to diagnose DME: Intravitreal injections involve placing anti-vascular endothelial growth factor (anti-VEGF) medications into the ...

Retinal pigment epithelial detachment is associated with neovascular age-related macular degeneration in 30% to 80% of cases, according to the literature.It is often difficult to treat, requires a ...

Types of wet AMD treatments. The main treatment involves eye injections of anti-VEGF drugs to stop problematic blood vessel growth. Options include aflibercept, bevacizumab, brolucizumab ...

Gene therapy is an area of intensive research and development in the retina space, with promising prospects and significant challenges. The benefits and pitfalls of gene therapy were discussed by two ...

Anti-VEGF shots. Anti-VEGF injections block a protein that causes abnormal blood vessel growth. Your doctor injects medicine into your eye after numbing it. Most people start with monthly ...